These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 35543151)
21. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells. Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells. Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715 [TBL] [Abstract][Full Text] [Related]
23. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539 [TBL] [Abstract][Full Text] [Related]
24. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α). Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360 [TBL] [Abstract][Full Text] [Related]
25. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells. Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780 [TBL] [Abstract][Full Text] [Related]
26. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma. Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290 [TBL] [Abstract][Full Text] [Related]
27. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α. Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933 [TBL] [Abstract][Full Text] [Related]
28. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence. Tan F; Zhu H; He X; Yu N; Zhang X; Xu H; Pei H Int J Mol Med; 2018 Aug; 42(2):935-945. PubMed ID: 29749460 [TBL] [Abstract][Full Text] [Related]
29. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145 [TBL] [Abstract][Full Text] [Related]
30. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis. Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579 [TBL] [Abstract][Full Text] [Related]
31. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Kaidi A; Qualtrough D; Williams AC; Paraskeva C Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642 [TBL] [Abstract][Full Text] [Related]
32. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365 [TBL] [Abstract][Full Text] [Related]
33. Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization. Bruno T; Valerio M; Casadei L; De Nicola F; Goeman F; Pallocca M; Catena V; Iezzi S; Sorino C; Desantis A; Manetti C; Blandino G; Floridi A; Fanciulli M J Exp Clin Cancer Res; 2017 Feb; 36(1):32. PubMed ID: 28214471 [TBL] [Abstract][Full Text] [Related]
34. Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism. Valli A; Morotti M; Zois CE; Albers PK; Soga T; Feldinger K; Fischer R; Frejno M; McIntyre A; Bridges E; Haider S; Buffa FM; Baban D; Rodriguez M; Yanes O; Whittington HJ; Lake HA; Zervou S; Lygate CA; Kessler BM; Harris AL Mol Cancer Res; 2019 Jul; 17(7):1531-1544. PubMed ID: 30885992 [TBL] [Abstract][Full Text] [Related]
35. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions. Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693 [TBL] [Abstract][Full Text] [Related]
37. Suppression of Myocardial Hypoxia-Inducible Factor-1α Compromises Metabolic Adaptation and Impairs Cardiac Function in Patients With Cyanotic Congenital Heart Disease During Puberty. Liu Y; Luo Q; Su Z; Xing J; Wu J; Xiang L; Huang Y; Pan H; Wu X; Zhang X; Li J; Yan F; Zhang H Circulation; 2021 Jun; 143(23):2254-2272. PubMed ID: 33663226 [TBL] [Abstract][Full Text] [Related]
38. Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells. Lu Y; Wang B; Shi Q; Wang X; Wang D; Zhu L Sci Rep; 2016 Dec; 6():39123. PubMed ID: 27982118 [TBL] [Abstract][Full Text] [Related]
39. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677 [TBL] [Abstract][Full Text] [Related]
40. Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas. Pietrafesa M; Maddalena F; Possidente L; Condelli V; Zoppoli P; Li Bergolis V; Rodriquenz MG; Aieta M; Vita G; Esposito F; Landriscina M Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]